异基因造血干细胞移植后巨细胞病毒感染及相关住院和费用数据集

数据集获取（Figshare）

• 源站标题：Cytomegalovirus infection and associated hospitalization and costs among individuals undergoing allogeneic hematopoietic stem cell transplant
• DOI：10.6084/m9.figshare.9778721.v2
• 发布日期：2019-09-23
• 文件数：4 个
• 文件总体积：349.50 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Cytomegalovirus_infection_and_associated_hospitalization_and_costs_among_individuals_undergoing_allogeneic_hematopoietic_stem_cell_transplant/9778721

命令行下载

curl -L -o "icmo_a_1664827_sm9835.docx" "https://ndownloader.figshare.com/files/17514011"
curl -L -o "icmo_a_1664827_sm9834.docx" "https://ndownloader.figshare.com/files/17514014"
curl -L -o "icmo_a_1664827_sm9833.docx" "https://ndownloader.figshare.com/files/17514017"
curl -L -o "icmo_a_1664827_sm9832.tif" "https://ndownloader.figshare.com/files/17514020"

文件清单

• icmo_a_1664827_sm9835.docx（18.13 KB）
• icmo_a_1664827_sm9834.docx（18.76 KB）
• icmo_a_1664827_sm9833.docx（16.41 KB）
• icmo_a_1664827_sm9832.tif（296.20 KB）

文件总体积 349.50 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Objective: This study utilized a large, national US database to explore the impact of Cytomegalovirus (CMV) infection on hospital services utilization and costs during the first 100 days following allogeneic hematopoietic stem cell transplant (allo-HSCT).
Methods: This retrospective, observational cohort study used data from the Premier Healthcare database to identify patients undergoing their first (index) allo-HSCT procedure between 1 January 2006 and 31 March 2015. Three subgroups were analyzed according to CMV-related readmissions during the 100-day follow-up (0, 1, or 2+ readmissions) to compare healthcare utilization and costs.
Results: A total of 1610 patients (mean age, 50.5 years; 56.9% male) from 52 US hospitals met the inclusion criteria. During follow-up, 212 (13.2%) patients had 1 (n = 161; 10.0%) or 2+ (n = 51; 3.2%) CMV-related readmissions. The mean ± SD number of all follow-up encounters (inpatient admissions and hospital-based outpatient visits) was similar for the no CMV (3.9 ± 3.9), 1 CMV (3.7 ± 3.9), and 2+ CMV (4.5 ± 3.8) readmission groups (p = .439). Mean total costs of hospital-based healthcare encounters (inpatient admissions and hospital-based outpatient visits) during follow-up were significantly greater in patients who had a CMV readmission ($111,729 [1 CMV readmission]; $184,021 [2+ CMV readmissions]) compared to those without a CMV readmission ($46,064; p p Conclusions: This large, national database study revealed significantly higher healthcare utilization and costs, as well as mortality, among patients with CMV-related re-hospitalization during the first 100 days post-transplant as compared to patients without CMV-related hospitalization.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.9778721.v2（source: https://tandf.figshare.com/articles/dataset/Cytomegalovirus_infection_and_associated_hospitalization_and_costs_among_individuals_undergoing_allogeneic_hematopoietic_stem_cell_transplant/9778721）。